Low Molecular Weight Heparin
- 1 October 1997
- journal article
- review article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 85 (4) , 874-885
- https://doi.org/10.1097/00000539-199710000-00031
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Prevention of Venous ThromboembolismChest, 1995
- Monitoring the Anticoagulant Effects of a Low Molecular Weight Heparin Preparation:Correlation of Assays in Orthopedic Surgery Patients Receiving Ardeparin Sodium for Prophylaxis of Deep Venous ThrombosisAmerican Journal of Clinical Pathology, 1995
- Anticoagulants and Spinal-Epidural AnesthesiaAnesthesia & Analgesia, 1994
- Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin™). An experimental investigation in healthy volunteersBlood Coagulation & Fibrinolysis, 1994
- Low molecular weight heparinsCurrent Opinion in Cardiology, 1994
- RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group.Journal of Bone and Joint Surgery, 1994
- A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee ImplantationNew England Journal of Medicine, 1993
- Prophylactic Agents for Venous Thrombosis in Elective Hip SurgeryArchives of internal medicine (1960), 1993
- Spinal epidural hematoma following epidural anesthesia versus spontaneous spinal subdural hematoma. Two case reportsActa Anaesthesiologica Scandinavica, 1991
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbitsBlood, 1982